Rationale and design of healthy at home for COPD: an integrated remote patient monitoring and virtual pulmonary rehabilitation pilot study.

Chronic obstructive pulmonary disease Digital medicine Digital phenotype Mobile integrated health

Journal

Pilot and feasibility studies
ISSN: 2055-5784
Titre abrégé: Pilot Feasibility Stud
Pays: England
ID NLM: 101676536

Informations de publication

Date de publication:
28 Oct 2024
Historique:
received: 26 01 2024
accepted: 16 10 2024
medline: 29 10 2024
pubmed: 29 10 2024
entrez: 29 10 2024
Statut: epublish

Résumé

Chronic obstructive pulmonary disease (COPD) is a common, costly, and morbid condition. Pulmonary rehabilitation, close monitoring, and early intervention during acute exacerbations of symptoms represent a comprehensive approach to improve outcomes, but the optimal means of delivering these services is uncertain. Logistical, financial, and social barriers to providing healthcare through face-to-face encounters, paired with recent developments in technology, have stimulated interest in exploring alternative models of care. The Healthy at Home study seeks to determine the feasibility of a multimodal, digitally enhanced intervention provided to participants with COPD longitudinally over 6 months. This paper details the recruitment, methods, and analysis plan for the study, which is recruiting 100 participants in its pilot phase. Participants were provided with several integrated services including a smartwatch to track physiological data, a study app to track symptoms and study instruments, access to a mobile integrated health program for acute clinical needs, and a virtual comprehensive pulmonary support service. Participants shared physiologic, demographic, and symptom reports, electronic health records, and claims data with the study team, facilitating a better understanding of their symptoms and potential care needs longitudinally. The Healthy at Home study seeks to develop a comprehensive digital phenotype of COPD by tracking and responding to multiple indices of disease behavior and facilitating early and nuanced responses to changes in participants' health status. This study is registered at Clinicaltrials.gov (NCT06000696).

Identifiants

DOI: 10.1186/s40814-024-01560-x PMID: 39468649
pubmed: 39468649
doi: 10.1186/s40814-024-01560-x
pii: 10.1186/s40814-024-01560-x
doi:

Banques de données

ClinicalTrials.gov
['NCT06000696']

Types de publication

Journal Article

Langues

eng

Pagination

131

Informations de copyright

© 2024. The Author(s).

Références

Centers for Disease Control and Prevention. Faststats: Chronic Lower Respiratory Disease. CDC. 2022.  https://www.cdc.gov/nchs/fastats/copd.htm .
Ford ES. Hospital discharges, readmissions, and ED visits for COPD or bronchiectasis among US adults: findings from the nationwide inpatient sample 2001–2012 and nationwide emergency department sample 2006–2011. Chest. 2015;147(4):989–98.
doi: 10.1378/chest.14-2146 pubmed: 25375955
Chatterjee K, Goyal A, Joshi M. Thirty-day readmissions in adults hospitalized for COPD or bronchiectasis: findings from the nationwide readmission database 2013. Chest. 2017;151(4):943–5.
doi: 10.1016/j.chest.2016.12.034 pubmed: 28390634
Viniol C, Vogelmeier CF. Exacerbations of COPD. Eur Respir Rev. 2018;27:147. https://doi.org/10.1183/16000617.0103-2017 .
doi: 10.1183/16000617.0103-2017
Blanchette CM, Gutierrez B, Ory C, Chang E, Akazawa M. Economic burden in direct costs of concomitant chronic obstructive pulmonary disease and asthma in a Medicare advantage population. J Manag Care Pharm. 2008;14(2):176–85.
pubmed: 18331119
AlHafidh OZ, Sidhu JS, Virk J, et al. Incidence, predictors, causes, and cost of 30-day hospital readmission in chronic obstructive pulmonary disease patients undergoing bronchoscopy. Cureus. 2020;12(6): e8607.
pubmed: 32550091 pmcid: 7294856
Pasquale MK, Sun SX, Song F, Hartnett HJ, Stemkowski SA. Impact of exacerbations on health care cost and resource utilization in chronic obstructive pulmonary disease patients with chronic bronchitis from a predominantly Medicare population. Int J Chron Obstruct Pulmon Dis. 2012;7:757–64.
doi: 10.2147/COPD.S36997 pubmed: 23152680 pmcid: 3496536
Mulpuru S, McKay J, Ronksley PE, Thavorn K, Kobewka DM, Forster AJ. Factors contributing to high-cost hospital care for patients with COPD. Int J Chron Obstruct Pulmon Dis. 2017;12:989–95.
doi: 10.2147/COPD.S126607 pubmed: 28392683 pmcid: 5373828
Press VG, Myers LC, Feemster LC. Preventing COPD readmissions under the hospital readmissions reduction program: how far have we come? Chest. 2021;159(3):996–1006.
doi: 10.1016/j.chest.2020.10.008 pubmed: 33065106
Wilkinson TMA, Donaldson GC, Hurst JR, Seemungal TAR, Wedzicha JA. Early therapy improves outcomes of exacerbations of chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2004;169(12):1298–303.
doi: 10.1164/rccm.200310-1443OC pubmed: 14990395
Yawn BP, Thomashow B. Management of patients during and after exacerbations of chronic obstructive pulmonary disease: the role of primary care physicians. Int J Gen Med. 2011;4:665–76.
doi: 10.2147/IJGM.S22878 pubmed: 21941453 pmcid: 3177593
Blanchette CM, Gross NJ, Altman P. Rising costs of COPD and the potential for maintenance therapy to slow the trend. Am Health Drug Benefits. 2014;7(2):98–106.
pubmed: 24991394 pmcid: 4049119
Sanchez-Morillo D, Fernandez-Granero MA, Jiménez AL. Detecting COPD exacerbations early using daily telemonitoring of symptoms and k-means clustering: a pilot study. Med Biol Eng Comput. 2015;53(5):441–51.
doi: 10.1007/s11517-015-1252-4 pubmed: 25725628
Lin WY, Verma VK, Lee MY, Lin HC, Lai CS. Prediction of 30-day readmission for COPD patients using accelerometer-based activity monitoring. Sensors. 2019;20(1). https://doi.org/10.3390/s20010217 .
Taylor ML, Thomas EE, Snoswell CL, Smith AC, Caffery LJ. Does remote patient monitoring reduce acute care use? A systematic review. BMJ Open. 2021;11(3): e040232.
doi: 10.1136/bmjopen-2020-040232 pubmed: 33653740 pmcid: 7929874
Cooper CB, Sirichana W, Arnold MT, et al. Remote patient monitoring for the detection of COPD exacerbations. Int J Chron Obstruct Pulmon Dis. 2020;15:2005–13.
doi: 10.2147/COPD.S256907 pubmed: 33061338 pmcid: 7519812
Fan KG, Mandel J, Agnihotri P, Tai-Seale M. Remote patient monitoring technologies for predicting chronic obstructive pulmonary disease exacerbations: review and comparison. JMIR Mhealth Uhealth. 2020;8(5): e16147.
doi: 10.2196/16147 pubmed: 32348262 pmcid: 7273236
Irwin DE, Atwood CA Jr, Hays RD, et al. Correlation of PROMIS scales and clinical measures among chronic obstructive pulmonary disease patients with and without exacerbations. Qual Life Res. 2015;24(4):999–1009.
doi: 10.1007/s11136-014-0818-1 pubmed: 25307510
Hibbard JH, Stockard J, Mahoney ER, Tusler M. Development of the Patient Activation Measure (PAM): conceptualizing and measuring activation in patients and consumers. Health Serv Res. 2004;39(4 Pt 1):1005–26.
doi: 10.1111/j.1475-6773.2004.00269.x pubmed: 15230939 pmcid: 1361049
Richards JB. Calculated decisions: mMRC (Modified Medical Research Council) dyspnea scale. Emerg Med Pract. 2017;19(Suppl 10):1–2.
pubmed: 29068638
Paladini L, Hodder R, Cecchini I, Bellia V, Incalzi RA. The MRC dyspnoea scale by telephone interview to monitor health status in elderly COPD patients. Respir Med. 2010;104(7):1027–34.
doi: 10.1016/j.rmed.2009.12.012 pubmed: 20116231
Jones PW, Harding G, Berry P, Wiklund I, Chen WH, Kline LN. Development and first validation of the COPD assessment test. Eur Respir J. 2009;34(3):648–54.
doi: 10.1183/09031936.00102509 pubmed: 19720809
Cooper CB, Sirichana W, Neufeld EV, Taylor M, Wang X, Dolezal BA. Statistical process control improves the feasibility of remote physiological monitoring in patients with chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis. 2019;14:2485–96.
doi: 10.2147/COPD.S207626 pubmed: 32009781 pmcid: 6859075
O’Connor L, Reznek M, Hall M, Inzerillo J, Broach JP, Boudreaux E. A mobile integrated health program for the management of undifferentiated acute complaints in older adults is safe and feasible. Acad Emerg Med. 2023;30(11):1110–6.
doi: 10.1111/acem.14791 pubmed: 37597241 pmcid: 10884993
Louras N, Reading Turchioe M, Shafran Topaz L, et al. Mobile integrated health interventions for older adults: a systematic review. Innov Aging. 2023;7(3):igad017.
doi: 10.1093/geroni/igad017 pubmed: 37090165 pmcid: 10114527
Thorlund K, Dron L, Park JJH, Mills EJ. Synthetic and external controls in clinical trials – a primer for researchers. Clin Epidemiol. 2020;12:457–67.
doi: 10.2147/CLEP.S242097 pubmed: 32440224 pmcid: 7218288
U.S. Food and Drug Administration. Considerations for the design and conduct of externally controlled trials for drug and biological products (Docket No. FDA-2022-D-2983). FDA; 2023. https://www.regulations.gov/docket/FDA-2022-D-2983/document .
Shah T, Press VG, Huisingh-Scheetz M, White SR. COPD readmissions: addressing COPD in the era of value-based health care. Chest. 2016;150(4):916–26.
doi: 10.1016/j.chest.2016.05.002 pubmed: 27167208 pmcid: 5812767
Lu CH, Clark CM, Tober R, et al. Readmissions and costs among younger and older adults for targeted conditions during the enactment of the hospital readmission reduction program. BMC Health Serv Res. 2021;21(1):386.
doi: 10.1186/s12913-021-06399-z pubmed: 33902569 pmcid: 8077835
Lu N, Huang KC, Johnson JA. Reducing excess readmissions: promising effect of hospital readmissions reduction program in US hospitals. Int J Qual Health Care. 2016;28(1):53–8.
doi: 10.1093/intqhc/mzv090 pubmed: 26573787
Miller BJ, Deutschendorf A, Brotman DJ. The hospital readmissions reduction program: inconvenient observations. J Hosp Med. 2021;16(7):448.
doi: 10.12788/jhm.3663 pubmed: 34197315
Sheehy AM, Kaiksow F, Powell WR, et al. The hospital readmissions reduction program and observation hospitalizations. J Hosp Med. 2021;16(7):409–11.
doi: 10.12788/jhm.3634 pubmed: 34197304 pmcid: 8248819

Auteurs

Laurel O'Connor (L)

Program in Digital Medicine, Department of Medicine, University of Massachusetts Chan Medical School, Worcester, MA, 01605, USA. laurel.oconnor@umassmed.edu.

Stephanie Behar (S)

Program in Digital Medicine, Department of Medicine, University of Massachusetts Chan Medical School, Worcester, MA, 01605, USA.
Division of Health System Science, University of Massachusetts Chan Medical School, Worcester, MA, USA.

Seanan Tarrant (S)

Program in Digital Medicine, Department of Medicine, University of Massachusetts Chan Medical School, Worcester, MA, 01605, USA.
Division of Health System Science, University of Massachusetts Chan Medical School, Worcester, MA, USA.

Pamela Stamegna (P)

Program in Digital Medicine, Department of Medicine, University of Massachusetts Chan Medical School, Worcester, MA, 01605, USA.

Caitlin Pretz (C)

Program in Digital Medicine, Department of Medicine, University of Massachusetts Chan Medical School, Worcester, MA, 01605, USA.
Division of Health System Science, University of Massachusetts Chan Medical School, Worcester, MA, USA.

Biqi Wang (B)

Program in Digital Medicine, Department of Medicine, University of Massachusetts Chan Medical School, Worcester, MA, 01605, USA.
Division of Health System Science, University of Massachusetts Chan Medical School, Worcester, MA, USA.

Brandon Savage (B)

CareEvolution, LLC, Ann Arbor, MI, USA.

Thomas Thomas Scornavacca (TT)

Department of Community Medicine and Family Health, University of Massachusetts Chan Medical School, Worcester, MA, USA.

Jeanne Shirshac (J)

Office of Clinical Integration, University of Massachusetts Memorial Healthcare, Worcester, MA, USA.

Tracey Wilkie (T)

Office of Clinical Integration, University of Massachusetts Memorial Healthcare, Worcester, MA, USA.

Michael Hyder (M)

Program in Digital Medicine, Department of Medicine, University of Massachusetts Chan Medical School, Worcester, MA, 01605, USA.
Office of Clinical Integration, University of Massachusetts Memorial Healthcare, Worcester, MA, USA.

Adrian Zai (A)

Program in Digital Medicine, Department of Medicine, University of Massachusetts Chan Medical School, Worcester, MA, 01605, USA.
Division of Health Informatics and Implementation Science, Department of Population and Quantitative Health Sciences, University of Massachusetts Chan Medical School, Worcester, USA.

Shaun Toomey (S)

Pulmonary, Allergy, and Critical Care Medicine, Department of Medicine, University of Massachusetts Chan Medical School, Worcester, MA, USA.

Marie Mullen (M)

Pulmonary, Allergy, and Critical Care Medicine, Department of Medicine, University of Massachusetts Chan Medical School, Worcester, MA, USA.

Kimberly Fisher (K)

Division of Health System Science, University of Massachusetts Chan Medical School, Worcester, MA, USA.
Pulmonary, Allergy, and Critical Care Medicine, Department of Medicine, University of Massachusetts Chan Medical School, Worcester, MA, USA.

Emil Tigas (E)

Pulmonary, Allergy, and Critical Care Medicine, Department of Medicine, University of Massachusetts Chan Medical School, Worcester, MA, USA.

Steven Wong (S)

Division of Health Informatics and Implementation Science, Department of Population and Quantitative Health Sciences, University of Massachusetts Chan Medical School, Worcester, USA.

David D McManus (DD)

Program in Digital Medicine, Department of Medicine, University of Massachusetts Chan Medical School, Worcester, MA, 01605, USA.
Division of Health System Science, University of Massachusetts Chan Medical School, Worcester, MA, USA.

Eric Alper (E)

Program in Digital Medicine, Department of Medicine, University of Massachusetts Chan Medical School, Worcester, MA, 01605, USA.

Peter K Lindenauer (PK)

Department of Healthcare Delivery and Population Sciences and Department of Medicine,, University of Massachusetts Chan Medical School-Baystate, Springfield, MA, USA.

Eric Dickson (E)

Program in Digital Medicine, Department of Medicine, University of Massachusetts Chan Medical School, Worcester, MA, 01605, USA.
Division of Health System Science, University of Massachusetts Chan Medical School, Worcester, MA, USA.

John Broach (J)

Program in Digital Medicine, Department of Medicine, University of Massachusetts Chan Medical School, Worcester, MA, 01605, USA.

Vik Kheterpal (V)

CareEvolution, LLC, Ann Arbor, MI, USA.

Apurv Soni (A)

Program in Digital Medicine, Department of Medicine, University of Massachusetts Chan Medical School, Worcester, MA, 01605, USA.
Division of Health System Science, University of Massachusetts Chan Medical School, Worcester, MA, USA.
Division of Health Informatics and Implementation Science, Department of Population and Quantitative Health Sciences, University of Massachusetts Chan Medical School, Worcester, USA.

Classifications MeSH